Guillain-Barre and Miller Fisher syndromes-new diagnostic classification

被引:392
作者
Wakerley, Benjamin R. [1 ]
Uncini, Antonino [2 ]
Yuki, Nobuhiro [3 ,4 ]
机构
[1] Gloucestershire Royal Hosp, Dept Neurol, Gloucester GL1 3NN, England
[2] Univ G DAnnunzio, Dept Neurosci Imaging & Clin Sci, I-66013 Chieti, Italy
[3] Natl Univ Singapore, Yong Loo Lin Sch Med, Ctr Translat Med, Dept Med, Singapore 117599, Singapore
[4] Natl Univ Singapore, Yong Loo Lin Sch Med, Ctr Translat Med, Dept Physiol, Singapore 117599, Singapore
基金
英国医学研究理事会;
关键词
BRAIN-STEM ENCEPHALITIS; SENSORY ATAXIC NEUROPATHY; CERVICAL-BRACHIAL VARIANT; ANTI-GQ1B IGG ANTIBODY; ANTIGANGLIOSIDE ANTIBODIES; CONTINUOUS-SPECTRUM; CLINICAL VARIANTS; OPHTHALMOPLEGIA; RECURRENT; PALSY;
D O I
10.1038/nrneurol.2014.138
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Guillain-Barre syndrome (GBS) and its variant, Miller Fisher syndrome (MFS), exist as several clinical subtypes with different neurological features and presentations. Although the typical clinical features of GBS and MFS are well recognized, current classification systems do not comprehensively describe the full spectrum of either syndrome. In this Perspectives article, GBS and MFS are classified on the basis of current understanding of the common pathophysiological profiles of each disease phenotype. GBS is subclassified into classic and localized forms (for example, pharyngeal-cervical-brachial weakness and bifacial weakness with paraesthesias), and MFS is divided into incomplete (for example, acute ophthalmoparesis, acute ataxic neuropathy) and CNS subtypes (Bickerstaff brainstem encephalitis). Diagnostic criteria based on clinical characteristics are suggested for each condition. We believe this approach to be more inclusive than existing systems, and argue that it could facilitate early clinical diagnosis and initiation of appropriate immunotherapy.
引用
收藏
页码:537 / 544
页数:8
相关论文
共 71 条
[1]  
[Anonymous], 1978, Ann Neurol, V3, P565
[2]  
[Anonymous], 1990, GUILLAIN BARRE SYNDR
[3]   Axonal pharyngeal-cervical-brachial variant of Guillain-Barre syndrome without anti-GT1a IgG antibody [J].
Arai, M ;
Susuki, K ;
Koga, M .
MUSCLE & NERVE, 2003, 28 (02) :246-250
[4]   ASSESSMENT OF CURRENT DIAGNOSTIC-CRITERIA FOR GUILLAIN-BARRE-SYNDROME [J].
ASBURY, AK ;
CORNBLATH, DR .
ANNALS OF NEUROLOGY, 1990, 27 :S21-S24
[5]   Hyperreflexic Guillain-Barre syndrome [J].
Baheti, Neeraj N. ;
Manuel, Davis ;
Shinde, Pranav D. ;
Radhakrishnan, Ashalatha ;
Nair, Muraleedharan .
ANNALS OF INDIAN ACADEMY OF NEUROLOGY, 2010, 13 (04) :305-306
[6]   MESENCEPHALITIS AND RHOMBENCEPHALITIS [J].
BICKERSTAFF, ER ;
CLOAKE, PCP .
BMJ-BRITISH MEDICAL JOURNAL, 1951, 2 (4723) :77-81
[7]   BRAIN-STEM ENCEPHALITIS - FURTHER OBSERVATIONS ON A GRAVE SYNDROME WITH BENIGN PROGNOSIS [J].
BICKERSTAFF, ER .
BRITISH MEDICAL JOURNAL, 1957, 1 (JUN15) :1384-1387
[8]   SERUM ANTI-GQ(1B) IGG ANTIBODY IS ASSOCIATED WITH OPHTHALMOPLEGIA IN MILLER FISHER SYNDROME AND GUILLAIN-BARRE-SYNDROME - CLINICAL AND IMMUNOHISTOCHEMICAL STUDIES [J].
CHIBA, A ;
KUSUNOKI, S ;
OBATA, H ;
MACHINAMI, R ;
KANAZAWA, I .
NEUROLOGY, 1993, 43 (10) :1911-1917
[9]  
CORNBLATH DR, 1991, NEUROLOGY, V41, P617